245 related articles for article (PubMed ID: 18678733)
1. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development.
Takizawa M; Tolarová H; Li Z; Dubois W; Lim S; Callen E; Franco S; Mosaico M; Feigenbaum L; Alt FW; Nussenzweig A; Potter M; Casellas R
J Exp Med; 2008 Sep; 205(9):1949-57. PubMed ID: 18678733
[TBL] [Abstract][Full Text] [Related]
2. Role of the translocation partner in protection against AID-dependent chromosomal translocations.
Jankovic M; Robbiani DF; Dorsett Y; Eisenreich T; Xu Y; Tarakhovsky A; Nussenzweig A; Nussenzweig MC
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):187-92. PubMed ID: 19966290
[TBL] [Abstract][Full Text] [Related]
3. AID is required for c-myc/IgH chromosome translocations in vivo.
Ramiro AR; Jankovic M; Eisenreich T; Difilippantonio S; Chen-Kiang S; Muramatsu M; Honjo T; Nussenzweig A; Nussenzweig MC
Cell; 2004 Aug; 118(4):431-8. PubMed ID: 15315756
[TBL] [Abstract][Full Text] [Related]
4. Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice.
Kotani A; Kakazu N; Tsuruyama T; Okazaki IM; Muramatsu M; Kinoshita K; Nagaoka H; Yabe D; Honjo T
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1616-20. PubMed ID: 17251349
[TBL] [Abstract][Full Text] [Related]
5. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations.
Robbiani DF; Bothmer A; Callen E; Reina-San-Martin B; Dorsett Y; Difilippantonio S; Bolland DJ; Chen HT; Corcoran AE; Nussenzweig A; Nussenzweig MC
Cell; 2008 Dec; 135(6):1028-38. PubMed ID: 19070574
[TBL] [Abstract][Full Text] [Related]
6. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.
Ramiro AR; Jankovic M; Callen E; Difilippantonio S; Chen HT; McBride KM; Eisenreich TR; Chen J; Dickins RA; Lowe SW; Nussenzweig A; Nussenzweig MC
Nature; 2006 Mar; 440(7080):105-9. PubMed ID: 16400328
[TBL] [Abstract][Full Text] [Related]
7. AID and Igh switch region-Myc chromosomal translocations.
Unniraman S; Schatz DG
DNA Repair (Amst); 2006 Sep; 5(9-10):1259-64. PubMed ID: 16784901
[TBL] [Abstract][Full Text] [Related]
8. Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
Casellas R; Yamane A; Kovalchuk AL; Potter M
Immunology; 2009 Mar; 126(3):316-28. PubMed ID: 19302140
[TBL] [Abstract][Full Text] [Related]
9. Distinct Patterns of Colocalization of the CCND1 and CMYC Genes With Their Potential Translocation Partner IGH at Successive Stages of B-Cell Differentiation.
Sklyar I; Iarovaia OV; Gavrilov AA; Pichugin A; Germini D; Tsfasman T; Caron G; Fest T; Lipinski M; Razin SV; Vassetzky YS
J Cell Biochem; 2016 Jul; 117(7):1506-10. PubMed ID: 26873538
[TBL] [Abstract][Full Text] [Related]
10. DSB structure impacts DNA recombination leading to class switching and chromosomal translocations in human B cells.
So CC; Martin A
PLoS Genet; 2019 Apr; 15(4):e1008101. PubMed ID: 30946744
[TBL] [Abstract][Full Text] [Related]
11. Amino-terminal phosphorylation of activation-induced cytidine deaminase suppresses c-myc/IgH translocation.
Gazumyan A; Timachova K; Yuen G; Siden E; Di Virgilio M; Woo EM; Chait BT; Reina San-Martin B; Nussenzweig MC; McBride KM
Mol Cell Biol; 2011 Feb; 31(3):442-9. PubMed ID: 21135131
[TBL] [Abstract][Full Text] [Related]
12. Translocation of an antibody transgene requires AID and occurs by interchromosomal switching to all switch regions except the mu switch region.
Shansab M; Eccleston JM; Selsing E
Eur J Immunol; 2011 May; 41(5):1456-64. PubMed ID: 21469111
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
Pérez-Durán P; de Yebenes VG; Ramiro AR
Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
[TBL] [Abstract][Full Text] [Related]
14. Myc translocations in B cell and plasma cell neoplasms.
Janz S
DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.
Compagno M; Wang Q; Pighi C; Cheong TC; Meng FL; Poggio T; Yeap LS; Karaca E; Blasco RB; Langellotto F; Ambrogio C; Voena C; Wiestner A; Kasar SN; Brown JR; Sun J; Wu CJ; Gostissa M; Alt FW; Chiarle R
Nature; 2017 Feb; 542(7642):489-493. PubMed ID: 28199309
[TBL] [Abstract][Full Text] [Related]
16. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
[TBL] [Abstract][Full Text] [Related]
17. Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc.
Unniraman S; Zhou S; Schatz DG
Nat Immunol; 2004 Nov; 5(11):1117-23. PubMed ID: 15489857
[TBL] [Abstract][Full Text] [Related]
18. Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.
Chen Z; Elos MT; Viboolsittiseri SS; Gowan K; Leach SM; Rice M; Eder MD; Jones K; Wang JH
J Hematol Oncol; 2016 Jan; 9():2. PubMed ID: 26740101
[TBL] [Abstract][Full Text] [Related]
19. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations.
Franco S; Gostissa M; Zha S; Lombard DB; Murphy MM; Zarrin AA; Yan C; Tepsuporn S; Morales JC; Adams MM; Lou Z; Bassing CH; Manis JP; Chen J; Carpenter PB; Alt FW
Mol Cell; 2006 Jan; 21(2):201-14. PubMed ID: 16427010
[TBL] [Abstract][Full Text] [Related]
20. Two new isotype-specific switching activities detected for Ig class switching.
Ma L; Wortis HH; Kenter AL
J Immunol; 2002 Mar; 168(6):2835-46. PubMed ID: 11884453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
